Cancer overdiagnosis: a biological challenge and clinical dilemma
For cancer screening to be successful, it should primarily detect cancers with lethal potential
or their precursors early, leading to therapy that reduces mortality and morbidity. Screening …
or their precursors early, leading to therapy that reduces mortality and morbidity. Screening …
ESR/ERS statement paper on lung cancer screening
HU Kauczor, AM Baird, TG Blum, L Bonomo… - European …, 2020 - Springer
In Europe, lung cancer ranks third among the most common cancers, remaining the biggest
killer. Since the publication of the first European Society of Radiology and European …
killer. Since the publication of the first European Society of Radiology and European …
Surgical treatment of lung cancer
H Hoy, T Lynch, M Beck - Critical Care Nursing Clinics, 2019 - ccnursing.theclinics.com
Lung cancer is the leading cause of cancer-related death and the second most diagnosed
cancer for both men and women in the United States 1, 2 More than 25, 000 surgeries for …
cancer for both men and women in the United States 1, 2 More than 25, 000 surgeries for …
Artificial intelligence in image reconstruction: the change is here
Innovations in CT have been impressive among imaging and medical technologies in both
the hardware and software domain. The range and speed of CT scanning improved from the …
the hardware and software domain. The range and speed of CT scanning improved from the …
Advancements in oncology with artificial intelligence—a review article
Simple Summary With the advancement of artificial intelligence, including machine learning,
the field of oncology has seen promising results in cancer detection and classification …
the field of oncology has seen promising results in cancer detection and classification …
[HTML][HTML] Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward
A Shankar, D Saini, A Dubey, S Roy… - … lung cancer research, 2019 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of all cancer deaths worldwide, comprising 18.4% of all
cancer deaths. Low-dose computed tomography (LDCT) has shown mortality benefit in …
cancer deaths. Low-dose computed tomography (LDCT) has shown mortality benefit in …
Biomarkers for lung cancer screening and detection
EJ Ostrin, D Sidransky, A Spira, SM Hanash - … epidemiology, biomarkers & …, 2020 - AACR
Lung cancer is the leading worldwide cause of cancer mortality, as it is often detected at an
advanced stage. Since 2011, low-dose CT scan–based screening has promised a 20 …
advanced stage. Since 2011, low-dose CT scan–based screening has promised a 20 …
[HTML][HTML] Long short-term memory model–a deep learning approach for medical data with irregularity in cancer predication with tumor markers
X Wu, HY Wang, P Shi, R Sun, X Wang, Z Luo… - Computers in Biology …, 2022 - Elsevier
Background Machine learning (ML) has emerged as a superior method for the analysis of
large datasets. Application of ML is often hindered by incompleteness of the data which is …
large datasets. Application of ML is often hindered by incompleteness of the data which is …
Uptake of lung cancer screening with low-dose computed tomography in China: A multi-centre population-based study
W Cao, F Tan, K Liu, Z Wu, F Wang, Y Yu, Y Wen… - …, 2022 - thelancet.com
Background Optimal uptake rates of low-dose computed tomography (LDCT) scans are
essential for lung cancer screening (LCS) to confer mortality benefits. We aimed to outline …
essential for lung cancer screening (LCS) to confer mortality benefits. We aimed to outline …
[HTML][HTML] Expression and prognostic potential of GPX1 in human cancers based on data mining
R Wei, H Qiu, J Xu, J Mo, Y Liu, Y Gui… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Glutathione peroxidase-1 (GPX1) is a member of the GPX family, which
considered an enzyme that interacts with oxidative stress. GPX1 differential expression is …
considered an enzyme that interacts with oxidative stress. GPX1 differential expression is …